{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:56:32Z","timestamp":1776448592559,"version":"3.51.2"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["NCT00526383"],"award-info":[{"award-number":["NCT00526383"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002738","name":"Assistance Publique Hopitaux de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.therap.2025.04.003","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:12:38Z","timestamp":1744492358000},"page":"625-630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blood glutamate levels in major depression with antidepressants and benzodiazepines: A 6-month prospective cohort study"],"prefix":"10.1016","volume":"80","author":[{"given":"Khalil","family":"El Asmar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tala","family":"El Ghoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Colle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rida","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Trabado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Feve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Verstuyft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Becquemont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Corruble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2025.04.003_bib0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/475027a","article-title":"Grand challenges in global mental health","volume":"475","author":"Collins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.therap.2025.04.003_bib0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapsychiatry.2017.1273","article-title":"Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001\u20132014","volume":"74","author":"Bushnell","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.therap.2025.04.003_bib0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/a-0836-7514","article-title":"Therapie der benzodiazepinabh\u00e4ngigkeit [Treatment of benzodiazepine dependence]","volume":"87","author":"Soyka","year":"2019","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.therap.2025.04.003_bib0090","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.therap.2025.04.003_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-319-55769-4_15","article-title":"Glutamate transporters in the blood-brain barrier","volume":"16","author":"Helms","year":"2017","journal-title":"Adv Neurobiol"},{"key":"10.1016\/j.therap.2025.04.003_bib0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0197-0186(03)00013-5","article-title":"Glutamine transport at the blood-brain and blood-cerebrospinal fluid barriers","volume":"43","author":"Xiang","year":"2003","journal-title":"Neurochem Int"},{"key":"10.1016\/j.therap.2025.04.003_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","article-title":"Glutamate uptake","volume":"65","author":"Danbolt","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.therap.2025.04.003_bib0110","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.psychres.2012.05.027","article-title":"Potential clinical utility of plasma amino acid profiling in the detection of major depressive disorder","volume":"200","author":"Xu","year":"2012","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.therap.2025.04.003_bib0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00228-009-0650-7","article-title":"The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression","volume":"65","author":"K\u00fc\u00e7\u00fckibrahimo\u011flu","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2025.04.003_bib0120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0447.1998.tb10004.x","article-title":"Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity","volume":"97","author":"Maes","year":"1998","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.therap.2025.04.003_bib0125","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s43440-024-00621-5","article-title":"Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder","volume":"76","author":"Krupa","year":"2024","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.therap.2025.04.003_bib0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1024\/0040-5930.66.6.485","article-title":"Spezielle Arzneimittelinteraktionen [Clinically relevant drug interactions with new generation antidepressants and antipsychotics]","volume":"66","author":"Eckert","year":"2009","journal-title":"Ther Umsch"},{"key":"10.1016\/j.therap.2025.04.003_bib0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2017.09.014","article-title":"Plasma amino acid profile in major depressive disorder: analyses in two independent case-control sample sets","volume":"96","author":"Ogawa","year":"2018","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.therap.2025.04.003_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-5198(19)30801-7","article-title":"Contribution of glutamate receptors to benzodiazepine withdrawal signs","volume":"81","author":"Tsuda","year":"1999","journal-title":"Jpn J Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595725000617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595725000617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:20:46Z","timestamp":1776446446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595725000617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0040595725000617"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2025.04.003","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood glutamate levels in major depression with antidepressants and benzodiazepines: A 6-month prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2025.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}